Cargando…

Agreement between MRI and pathologic breast tumor size after neoadjuvant chemotherapy, and comparison with alternative tests: individual patient data meta-analysis

BACKGROUND: Magnetic resonance imaging (MRI) may guide breast cancer surgery by measuring residual tumor size post-neoadjuvant chemotherapy (NAC). Accurate measurement may avoid overly radical surgery or reduce the need for repeat surgery. This individual patient data (IPD) meta-analysis examines MR...

Descripción completa

Detalles Bibliográficos
Autores principales:	Marinovich, Michael L., Macaskill, Petra, Irwig, Les, Sardanelli, Francesco, Mamounas, Eleftherios, von Minckwitz, Gunter, Guarneri, Valentina, Partridge, Savannah C., Wright, Frances C., Choi, Jae Hyuck, Bhattacharyya, Madhumita, Martincich, Laura, Yeh, Eren, Londero, Viviana, Houssami, Nehmat
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2015
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4599727/ https://www.ncbi.nlm.nih.gov/pubmed/26449630 http://dx.doi.org/10.1186/s12885-015-1664-4

Ejemplares similares

Meta-analysis of agreement between MRI and pathologic breast tumour size after neoadjuvant chemotherapy
por: Marinovich, M L, et al.
Publicado: (2013)

Rates of reoperation after breast conserving cancer surgery in Western Australia before and after publication of the SSO-ASTRO margins guideline
por: Marinovich, M. Luke, et al.
Publicado: (2023)

Women’s views on overdiagnosis in breast cancer screening: a qualitative study
por: Hersch, Jolyn, et al.
Publicado: (2013)

Neoadjuvant nab-paclitaxel in the treatment of breast cancer
por: Ueno, Naoto T., et al.
Publicado: (2016)

Differential detection by breast density for digital breast tomosynthesis versus digital mammography population screening: a systematic review and meta-analysis
por: Li, Tong, et al.
Publicado: (2022)

Using patient management as a surrogate for patient health outcomes in diagnostic test evaluation
por: Staub, Lukas P, et al.
Publicado: (2012)

Overdetection in breast cancer screening: development and preliminary evaluation of a decision aid
por: Hersch, Jolyn, et al.
Publicado: (2014)

Evidence from a BreastScreen cohort does not support a longer inter-screen interval in women who have no conventional risk factors for breast cancer
por: Noguchi, Naomi, et al.
Publicado: (2022)

Screening outcomes by risk factor and age: evidence from BreastScreen WA for discussions of risk‐stratified population screening
por: Noguchi, Naomi, et al.
Publicado: (2021)

Two-year follow-up of participants in the BreastScreen Victoria pilot trial of tomosynthesis versus mammography: breast density-stratified screening outcomes
por: Houssami, Nehmat, et al.
Publicado: (2023)

How information about overdetection changes breast cancer screening decisions: a mediation analysis within a randomised controlled trial
por: Hersch, Jolyn, et al.
Publicado: (2017)

Informing Women About Overdetection in Breast Cancer Screening: Two-Year Outcomes From a Randomized Trial
por: Hersch, Jolyn, et al.
Publicado: (2021)

State of the art in neoadjuvant therapy of breast cancer
por: Minckwitz, Gunter von, et al.
Publicado: (2013)

A systematic review of the impact of the COVID-19 pandemic on breast cancer screening and diagnosis
por: Li, Tong, et al.
Publicado: (2023)

The effect of information about overdetection of breast cancer on women's decision-making about mammography screening: study protocol for a randomised controlled trial
por: Hersch, Jolyn, et al.
Publicado: (2014)

Overdiagnosis of breast cancer in population screening: does it make breast screening worthless?
por: Houssami, Nehmat
Publicado: (2017)

Can population breast screening programs be leveraged to reduce the burden of breast cancer?
por: Houssami, Nehmat
Publicado: (2021)

Artificial intelligence (AI) for breast cancer screening: BreastScreen population-based cohort study of cancer detection
por: Marinovich, M. Luke, et al.
Publicado: (2023)

Recent advances in systemic therapy. Advances in neoadjuvant (primary) systemic therapy with cytotoxic agents
por: Untch, Michael, et al.
Publicado: (2009)

An assessment of the relationship between clinical utility and predictive ability measures and the impact of mean risk in the population
por: McGeechan, Kevin, et al.
Publicado: (2014)

Patients who take their symptoms less seriously are more likely to have colorectal cancer
por: Adelstein, Barbara-Ann, et al.
Publicado: (2012)

Impact of Full-Field Digital Mammography Versus Film-Screen Mammography in Population Screening: A Meta-Analysis
por: Farber, Rachel, et al.
Publicado: (2020)

Neoadjuvant Systemic Therapy for Breast Cancer: Factors Influencing Surgeons’ Referrals
por: Mamounas, Eleftherios, et al.
Publicado: (2016)

A self administered reliable questionnaire to assess lower bowel symptoms
por: Adelstein, Barbara-Ann, et al.
Publicado: (2008)

Screening women with a personal history of breast cancer: overview of the evidence on breast imaging surveillance
por: Houssami, Nehmat, et al.
Publicado: (2018)

The epidemiology, radiology and biological characteristics of interval breast cancers in population mammography screening
por: Houssami, Nehmat, et al.
Publicado: (2017)

Pathologic Complete Response of HER-2 Neu-Positive Invasive Ductal Carcinoma and Ductal Carcinoma In Situ following Neoadjuvant Chemotherapy plus Trastuzumab: A Case Report and Review of Literature
por: Gunia, Sommer R., et al.
Publicado: (2012)

Most bowel cancer symptoms do not indicate colorectal cancer and polyps: a systematic review
por: Adelstein, Barbara-Ann, et al.
Publicado: (2011)

The value of age and medical history for predicting colorectal cancer and adenomas in people referred for colonoscopy
por: Adelstein, Barbara-Ann, et al.
Publicado: (2011)

Staging the axilla in women with breast cancer: the utility of preoperative ultrasound-guided needle biopsy
por: Houssami, Nehmat, et al.
Publicado: (2014)

Towards consensus on managing high mammographic density in population breast screening?
por: Tagliafico, Alberto Stefano, et al.
Publicado: (2023)

Surgical management of the breast and axilla after neoadjuvant treatment: the role of sentinel node biopsy
por: Mamounas, EP
Publicado: (2009)

The reliability of a quality appraisal tool for studies of diagnostic reliability (QAREL)
por: Lucas, Nicholas, et al.
Publicado: (2013)

Estimation of treatment preference effects in clinical trials when some participants are indifferent to treatment choice
por: Walter, Stephen D., et al.
Publicado: (2017)

Correction to: Estimation of treatment preference effects in clinical trials when some participants are indifferent to treatment choice
por: Walter, Stephen D., et al.
Publicado: (2020)

New technologies in screening for breast cancer: a systematic review of their accuracy
por: Irwig, L, et al.
Publicado: (2004)

Value of routine monitoring of bone mineral density after starting bisphosphonate treatment: secondary analysis of trial data
por: Bell, Katy J L, et al.
Publicado: (2009)

Apparent diffusion coefficient cannot predict molecular subtype and lymph node metastases in invasive breast cancer: a multicenter analysis
por: Surov, Alexey, et al.
Publicado: (2019)

Hormone replacement therapy use dramatically increases breast oestrogen receptor expression in obese postmenopausal women
por: Lawson, James S, et al.
Publicado: (2001)

Artificial intelligence (AI) in breast cancer care - Leveraging multidisciplinary skills to improve care()
por: Cardoso, Maria Joao, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_bvvi1niden1omac5auqi4342tq